Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1987-12-1
|
pubmed:abstractText |
We determined the effect of plasma obtained from rats treated with DOCA-salt for 6 and 28 days on sodium pump activity, measured as ouabain-sensitive Rb+ uptake in tail arteries from these rats. The effect of an electrolytic lesion in the area of the anteroventral third cerebral ventricle (AV3V) before DOCA-salt treatment was investigated in relation to the ability of plasma to inhibit vascular Na+ pump activity. Systolic blood pressures, plasma sodium and potassium concentrations, body weights and haematocrit were also measured. Six days after DOCA-salt treatment, there was a 22% suppression of vascular Na+ pump activity in these rats. This suppression was due to a plasma factor since plasma from these rats produced a similar degree of suppression in arteries isolated from untreated control rats. Furthermore, tail arteries from DOCA-salt rats treated for 6 days displayed normal Na+ pump activity when incubated in plasma from control rats or in Krebs-Henseleit buffer. There was no elevation of systolic blood pressure at the end of 6 days of treatment with DOCA-salt. Placement of an electrolytic brain lesion in the AV3V area before treatment with DOCA-salt abolished the ability of plasma to inhibit the vascular Na+ pump. Treatment with DOCA-salt for 28 days resulted in a significant increase in systolic blood pressure, a decrease in plasma potassium concentration, and a significant increase in vascular Na+ pump activity (26%).(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/ATPase inhibitory protein,
http://linkedlifedata.com/resource/pubmed/chemical/Blood Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Desoxycorticosterone,
http://linkedlifedata.com/resource/pubmed/chemical/Ouabain,
http://linkedlifedata.com/resource/pubmed/chemical/Potassium,
http://linkedlifedata.com/resource/pubmed/chemical/Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Rubidium Radioisotopes,
http://linkedlifedata.com/resource/pubmed/chemical/Sodium Chloride
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0263-6352
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
461-7
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:3668248-Animals,
pubmed-meshheading:3668248-Biological Transport, Active,
pubmed-meshheading:3668248-Blood Proteins,
pubmed-meshheading:3668248-Cerebral Ventricles,
pubmed-meshheading:3668248-Desoxycorticosterone,
pubmed-meshheading:3668248-Hypertension,
pubmed-meshheading:3668248-Male,
pubmed-meshheading:3668248-Ouabain,
pubmed-meshheading:3668248-Potassium,
pubmed-meshheading:3668248-Proteins,
pubmed-meshheading:3668248-Rats,
pubmed-meshheading:3668248-Rats, Inbred Strains,
pubmed-meshheading:3668248-Rubidium Radioisotopes,
pubmed-meshheading:3668248-Sodium Chloride
|
pubmed:year |
1987
|
pubmed:articleTitle |
Effect of DOCA-salt treatment duration and anteroventral third ventricle lesions on a plasma-borne sodium pump inhibitor in rats.
|
pubmed:affiliation |
Department of Pharmacology, University of Tennessee, Memphis 38163.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|